211513-21-2

Basic information

• Product Name: 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide
• Synonyms: 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide;CyclohexanecarboxaMide, 1-(2-ethylbutyl)-N-(2-Mercaptophenyl)-;1-(2-ETHYLBUTYL)-N-(2-MERCAPTOPHENYL)CYCLOHEXANECARBOXAMIDE
• CAS NO: 211513-21-2
• Molecular Formula: C₁₉H₂₉NOS
• Molecular Weight: 319.50466
• EINECS: -0
• Mol File: 211513-21-2.mol
• Article Data: 3

Chemical Properties

• Melting Point: 68.5-74 °C
• Boiling Point: 473.8°C at 760 mmHg
• Flash Point: 240.4°C
• Appearance: /
• Density: 1.064g/cm³
• Vapor Pressure: 3.8E-09mmHg at 25°C
• Refractive Index: 1.562
• PKA: 6.49±0.43(Predicted)
• CAS DataBase Reference: 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide(211513-21-2)
• EPA Substance Registry System: 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide(211513-21-2)

Safety Data

• Hazardous Substances Data: 211513-21-2(Hazardous Substances Data)

Usage

General Description

1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide is a chemical compound with the molecular formula C20H31NO2S. It is a carboxamide derivative with a cyclohexane ring, an ethylbutyl side chain, and a sulfanylphenyl group. 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxaMide may have potential applications in the pharmaceutical industry, as carboxamides are known to exhibit a wide range of biological activities. Additionally, the presence of the sulfanyl group could contribute to the compound's reactivity and potential pharmacological properties. Further research is needed to fully understand the potential uses and properties of 1-(2-Ethylbutyl)-N-(2-sulfanylphenyl)cyclohexanecarboxamide.

InChI:InChI=1/C19H29NOS/c1-3-15(4-2)14-19(12-8-5-9-13-19)18(21)20-16-10-6-7-11-17(16)22/h6-7,10-11,15,22H,3-5,8-9,12-14H2,1-2H3,(H,20,21)

Upstream product

• 211513-15-4 bis-[2-[1-(2-ethylbutyl)cyclohexanecarbonylamino]phenyl]disulfide 
• 98-89-5 Cyclohexanecarboxylic acid 
• 211515-46-7 1-(2-ethyl-butyl)-cyclohexanecarbonyl chloride 
• 3814-34-4 2-ethyl-1-bromobutane 
• 381209-09-2 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid 

Downstream Products

• 211513-37-0 dalcetrapib 

Relevant articles and documents

New Process

The present invention relates to a process for the preparation of S-[2-[1-(2-ethylbutyl)cyclohexylcarbonylamino]-phenyl]2-methylthiopropionate which is useful as a pharmaceutically active compound.

Bis(2-(acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein

A series of bis(2-(acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, S-(2-(acylamino)-phenyl) alkanethioates, and related compounds were synthesized, and their inhibitory effect on cholesteryl ester transfer protein activity in human plasma was evaluated. This study elucidated the structural requirements for inhibitory activity and determined that the optimum compound was S-(2-((1-(2-ethylbutyl)cyclohexane)carbonylamino)phenyl) 2-methylpropanethioate (27) (JTT-705). This compound achieved 50% inhibition of CETP activity in human plasma at a concentration of 9 μM and 95% inhibition of CETP activity in male Japanese white rabbits at an oral dose of 30 mg/kg. It increased the plasma HDL cholesterol level by 27% and 54%, respectively, when given at oral doses of 30 or 100 mg/kg once a day for 3 days to male Japanese white rabbits.